
Pfizer announced Tuesday projected combined sales of its COVID vaccine and antiviral drug Paxlovid should top $54 billion in 2022, but the company’s stock dropped sharply today. By David Charbonneau, Ph.D. Children’s Health Defense Miss a day, miss a lot. Subscribe to The Defender’s Top News of the Day. It’s free. Pfizer […]